Fluticasone Furoate & Azelastine Hydrochloride Nasal Spray

  • Fluticasone Furoate & Azelastine Hydrochloride Nasal Spray 1
  • Fluticasone Furoate & Azelastine Hydrochloride Nasal Spray 2
Product Description

Azelastine and fluticasone combination nasal spray is used to treat an itchy or runny nose, sneezing, or other symptoms caused by seasonal hay fever (allergic rhinitis). Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which is produced by the body.

Read more Show less

Biodeal pharmaceuticals Ltd.

  • Country/Region:
    India
  • Founded:
    2005
  • On CPHI since:
    2017
  • Certificates:
    5
  • Employees:
    500 - 999
Company types
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Contract Research Organisation
Nutraceuticals
Out-licensing specialist
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    Each Spray delivers:                                                    Fluticasone Furoate ……………..………27.5 mcg       
        Azelastine Hydrochloride IP…………..….140 mcg         


    10 ml Pack - HDPE  Bottle with Metered Dose SPRAY  Pump.   
  • Selling Points
    Anti-Allergens; Azelastine and fluticasone combination nasal spray is used to treat an itchy or runny nose, sneezing, or other symptoms caused by seasonal hay fever (allergic rhinitis). Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which is produced by the body.Azelastine Nasal Spray is Safe and Effective at a Dosage of 1 Spray per Nostril Twice Daily in Patients with Seasonal Allergic RhinitisIn the combined analysis, azelastine nasal spray significantly (P<. 001) improved the TNSS compared to cetirizine by a mean of 32.5% vs 24.6%. Azelastine nasal spray also improved all four symptoms of the TNSS compared to cetirizine (P≤ . 01).
  • Model
    10 ml pack
  • Supplied from
    India
  • Measured In
    piece
More specifications Fewer specifications
Sales Markets
Show more Show less

Biodeal pharmaceuticals Ltd.

  • Country/Region:
    India
  • Founded:
    2005
  • On CPHI since:
    2017
  • Certificates:
    5
  • Employees:
    500 - 999
Company types
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Contract Research Organisation
Nutraceuticals
Out-licensing specialist
Pharmaceutical Company (generic finished products)
View company profile

More Products from Biodeal pharmaceuticals Ltd. (3)

  • Beclometasone Nasal Spray

    Product Beclometasone Nasal Spray

    Why is this medication prescribed?Beclomethasone nasal spray is used to relieve symptoms of sneezing, runny, stuffy, or itchy nose (rhinitis) caused by hay fever, other allergies, or vasomotor (nonallergic) rhinitis. It is also used to prevent nasal polyps (swelling of the lining of the nose) after nasal p...
  • Fluticasone Fuortae NASAL SPRAY

    Product Fluticasone Fuortae NASAL SPRAY

    Each spray delivers:                                                       Fluticasone Furoate IH......................... 27.5 mcg   
    10 ml pack - H...
  • MIDAZOLAM NASAL SPRAY

    Product MIDAZOLAM NASAL SPRAY

    MECHANISM OF ACTION

    Midazolam acts as an agonist at the benzodiazepine receptors by forming a component of the midazolam-GABA receptor-chloride ionophore complex. This binding increases the permeability of the central pore of the receptor to chloride ion into the neuron. Increas...

Biodeal pharmaceuticals Ltd. resources (1)

  • Biodeal Pharmaceuticals - Company Profile

    Brochure Biodeal Pharmaceuticals - Company Profile

    Biodeal Pharmaceuticals Limited is a WHO-GMP and PIC/S certified, USFDA-compliant Contract Development and Manufacturing Organisation (CDMO) founded in 2005. Headquartered in Noida with manufacturing facilities across Himachal Pradesh, we serve 1000+ clients across 80+ countries with a portfolio of 1,000+ formulations and 100+ global regulatory registrations. 

    India's leading nasal spray CDMO. Largest innovative range globally across 20+ formulations including complex molecules. State-of-the-art nasal filling line with advanced plume geometry, particle size and spray pattern testing. Three DCGI approvals in 2024–25. Active pipeline of India-first and global-first molecules.

    Injectables: dedicated advanced sterile manufacturing facility at Paonta Sahib. 12 production lines across general injectables, broad-range carbapenems and hormone injectables.